Log In
Print
BCIQ
Print
Print this Print this
 

Arilvax

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionLive attenuated vaccine against yellow fever
Molecular Target Not available
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: Viral vaccine
Latest Stage of DevelopmentMarketed
Standard IndicationYellow fever
Indication DetailsPrevent yellow fever
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today